Alice P. Albright

Chief Executive Officer at Millennium Challenge Corp.

Health Technology

Government

Profile

Alice P.
Albright is currently the Chief Executive Officer at Millennium Challenge Corp.
Prior to this, she was the Director-Emeritus at International AIDS Vaccine Initiative, Inc.

Alice P. Albright active positions

Companies	Position	Start
Millennium Challenge Corp.	Chief Executive Officer	01/02/2022

All active positions of Alice P. Albright

Former positions of Alice P. Albright

Companies	Position	End
International AIDS Vaccine Initiative, Inc. International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY.	Director/Board Member	-

See the detail of Alice P. Albright's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alice P. Albright's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
International AIDS Vaccine Initiative, Inc. International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY.	Health Technology
Millennium Challenge Corp.	Government